Skip to main content
All inhalers

PULMICORT FLEXHALER

Budesonide

PULMICORT FLEXHALER

ICS DPI

Budesonide · AstraZeneca

Clinical Reference

Active Medication & Mechanism

  • Budesonide ICS
    90 mcg or 180 mcg per actuation (delivers approximately 80 mcg or 160 mcg from the mouthpiece)

    Corticosteroid with potent glucocorticoid and weak mineralocorticoid activity. Reduces airway inflammation by inhibiting inflammatory cell recruitment and cytokine production.

FDA-Approved Dosing by Indication

// approval varies by strength + age
Asthma
3/4 approved regimens
  • 180 mcg FDA Approved
    Pop · Adults and adolescents ≥18 years (previously on bronchodilators alone)
    2 inhalations (360 mcg) twice daily
    Starting dose. Maximum dose is 720 mcg twice daily (1440 mcg/day).
    Total · 720 mcg
  • 180 mcg FDA Approved
    Pop · Adults (previously on ICS)
    2 inhalations (360 mcg) twice daily
    Starting dose for step-across from another ICS.
    Total · 720 mcg
  • 180 mcg FDA Approved
    Pop · Adults (previously on oral corticosteroids)
    2–4 inhalations twice daily
    For oral steroid taper. Max 1440 mcg/day.
    Total · 720–1440 mcg
  • Any strength Not Approved
    Pop · Acute bronchospasm
    Total · Not a bronchodilator. Not for acute relief. Use a SABA.
Acute Use
0/1 approved regimens
  • Any strength Not Approved
    Pop · Acute bronchospasm / rescue
    Total · Not for acute use. Use a SABA.

For clinical reference only. This workspace is intended for use by qualified healthcare professionals and is not a substitute for clinical judgement, prescribing information, or product monographs. Always verify doses and indications against the most current labelling before prescribing.

Inhaler Database · © inhalerdatabase.com 2024–2026 — All rights reserved